Synonyms: Besivance® | BOL-303224-A | ISV-403 | SS734
besifloxacin is an approved drug (FDA (2009))
Compound class:
Synthetic organic
Comment: Besifloxacin is a fluoroquinolone compound with broad-spectrum antibacterial activity against Gram-positive and Gram-negative pathogens [1-2].
|
|
References |
1. Haas W, Pillar CM, Zurenko GE, Lee JC, Brunner LS, Morris TW. (2009)
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria. Antimicrob Agents Chemother, 53 (8): 3552-60. [PMID:19506065] |
2. Ward KW, Lepage JF, Driot JY. (2007)
Nonclinical pharmacodynamics, pharmacokinetics, and safety of BOL-303224-A, a novel fluoroquinolone antimicrobial agent for topical ophthalmic use. J Ocul Pharmacol Ther, 23 (3): 243-56. [PMID:17593008] |